Cream

Known as: Cream Dosage Form, Cream Dose Form, Cream [Dose Form] 
A semi-solid composed of an emulsion of lipids, hydrocarbons, waxes, or polyols in water.
National Institutes of Health

Related topics

Related topics

6 relations
CDISC CDASH Concomitant Medication Dose Form TerminologyCDISC SDTM Pharmaceutical Dosage Form TerminologyClinical Data Interchange Standards Consortium TerminologyStructured Product Labeling Pharmaceutical Dosage Form Terminology

Narrower (2)

Emollient CreamTopical Cream

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2005
Highly Cited
2005
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe.
BACKGROUND Imiquimod is an immune response modifier that acts through toll-like receptor 7 to induce cytokine production and a… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies.
BACKGROUND Imiquimod is an immune response modifier that is a Toll-like receptor 7 agonist that induces interferon and other… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials.
BACKGROUND The immune system plays a critical role in the development and pathogenesis of actinic keratosis (AK). Imiquimod has… (More)
  • figure 1
  • table I
  • table II
  • table III
  • figure 2
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Imiquimod 5% cream for the treatment of actinic keratosis: results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology.
BACKGROUND Increasing evidence suggests imiquimod may be a safe therapeutic option for the treatment of actinic keratosis (AK… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study.
BACKGROUND Imiquimod 5% cream may provide an effective nonsurgical treatment for superficial basal cell carcinoma (sBCC) based on… (More)
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 5
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents.
BACKGROUND The ascomycin derivative pimecrolimus (ASM 981) is a cell-selective cytokine inhibitor, specifically developed for the… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial.
BACKGROUND Superficial basal cell carcinoma (sBCC) is an increasingly common tumor in fair-skinned populations throughout the… (More)
Is this relevant?
2000
2000
Clinical study of SS-cream in patients with lifelong premature ejaculation.
OBJECTIVES To investigate the clinical efficacy of SS-cream, the topical agent made from the extracts of nine natural products… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
OBJECTIVE To compare the safety and effectiveness of 5% and 1% imiquimod cream with vehicle cream in the treatment of external… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1997
Highly Cited
1997
Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients.
PURPOSE A minority of cancer survivors develops long-term postsurgical neuropathic pain. Based on evidence that capsaicin, the… (More)
Is this relevant?